D-Cubed Full report
Regulatory Insights
Oncology & Hematology
Rare / Genetic Disease
Autoimmune / Inflammatory Disease
Launch
Pre-launch
Publication: D-Cubed Full report 2025
D-Cubed Pharma brings together the complete three-part series authored by Peter Keeling, Founder and Board Chair at Diaceutics PLC.
Drawing on more than a decade of biomarker-driven launches and extensive real-world evidence, the series explores how combining Diagnostics, Data, and Digital is redefining launch performance, expanding patient reach, and establishing a new commercial standard for pharma in 2026 and beyond.
Author(s): Founder and Board Chair at Diaceutics PLC.
Year: 2025